Last reviewed · How we verify
IV Baclofen
At a glance
| Generic name | IV Baclofen |
|---|---|
| Sponsor | Allaysis, LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump (PHASE3)
- Repeated Dose IV Baclofen Safety/Bioequivalence Study (PHASE1, PHASE2)
- Oral and IV Baclofen in Adult Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IV Baclofen CI brief — competitive landscape report
- IV Baclofen updates RSS · CI watch RSS
- Allaysis, LLC portfolio CI